Skip to main content

Table 1 Clinical characteristics of the patients

From: Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

  Treated (n = 12) Not treated (n = 10)
Age (years) [median; min–max] 12.2; 8–16 11.5; 7–16
BMI [median; min–max] 17.1; 12.5–23.5 16.7; 14.2–20.8
Polydipsia at diagnosis (number of patients) 5 8
Polyuria at diagnosis (number of patients) 5 3
Loss of weight at diagnosis (number of patients) 4 3
pH at diagnosis (capillary blood) [median; min–max] 7.40; 7.36–7.42 7.39; 7.35–7.53
pO2 at diagnosis (capillary blood—mmHg) [median; min–max] 69.3; 24.1–88.0 69.5; 56.0–86.6
pCO2 at diagnosis (capillary blood—mmHg) [median; min–max] 39.6; 28.0–46.9 38.0; 24.0–40.7
HCO3 at diagnosis (capillary blood—mmHg) [median; min–max] 24.15; 18.8–27.4 23.6; 21.3–25.2
Acid/base balance at diagnosis (BE—mEq/l) [median; min–max] 0.05; −7.8–3.2 −0.5; −3.8–0.9
Sat02 at diagnosis (capillary blood—%) [median; min–max] 94.1; 90.2–97.3 95.4; 92.4–97.2
Anti-GAD65 antibody (number of patients) 9 9
ICA (number of patients) 7 5
IAA (number of patients) 7 4